Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Clump

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Cardio-Oncology (London, England)|June 19, 2026
A systematic review of artificial intelligence in radiotherapy associated cardiovascular toxicityVivian Salama, Brandon M Godinich, Nathaniel Dunham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck CancerRobert L Ferris, Jessica Moskovitz, Sheryl Kunning, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|December 7, 2022
A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patientsJanielle K-A Taylor, Leila J Mady, Khalil Baddour, et al.
Cancers|July 2, 2021
NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck CancerJulie E Bauman, Jonathan Harris, Ravindra Uppaluri, et al.
Head & Neck|April 25, 2020
Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experienceHarish Dharmarajan, Jennifer L Anderson, Seungwon Kim, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2024
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgeryLisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, et al.
The Lancet. Oncology|January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trialEric J Sherman, Jonathan Harris, Keith C Bible, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2022
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504Maura L Gillison, Robert L Ferris, Jonathan Harris, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cardio-Oncology (London, England)|June 19, 2026
A systematic review of artificial intelligence in radiotherapy associated cardiovascular toxicityVivian Salama, Brandon M Godinich, Nathaniel Dunham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck CancerRobert L Ferris, Jessica Moskovitz, Sheryl Kunning, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|December 7, 2022
A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patientsJanielle K-A Taylor, Leila J Mady, Khalil Baddour, et al.
Cancers|July 2, 2021
NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck CancerJulie E Bauman, Jonathan Harris, Ravindra Uppaluri, et al.
Head & Neck|April 25, 2020
Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experienceHarish Dharmarajan, Jennifer L Anderson, Seungwon Kim, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2024
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgeryLisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, et al.
The Lancet. Oncology|January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trialEric J Sherman, Jonathan Harris, Keith C Bible, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2022
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504Maura L Gillison, Robert L Ferris, Jonathan Harris, et al.
Pageof 8